Wednesday July 26, 2017 05:44

Heathcare Press Release : 07 Jul 2017

ALK - Five-year GRAZAX(R) Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Heathcare—07 Jul 17

- The disease modifying property of GRAZAX(R) (SQ(R) grass SLIT-tablet) resulted in long-term effect on allergic rhinoconjunctivitis (ARC) and prevented asthma symptoms, even two years after end of treatment in children with grass pollen ARC and no